Protective effect of melatonin-supported adipose-derived mesenchymal stem cells against small bowel ischemia-reperfusion injury in rat

Journal of Pineal Research

Volumn 59, Issue 2, 2015, Pages 206-220

  Chang, Chia Lo ^a   Sung, Pei Hsun ^a   Sun, Cheuk Kwan ^b   Chen, Chih Hung ^a   Chiang, Hsin Ju ^a   Huang, Tien Hung ^a   Chen, Yi Ling ^a   Zhen, Yen Yi ^a   Chai, Han Tan ^a   Chung, Sheng Ying ^a   Tong, Meng Shen ^a   Chang, Hsueh Wen ^c   Chen, Hong Hwa ^a   Yip, Hon Kan ^a,d  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

apoptosis; inflammation; ischemia reperfusion injury; oxidative stress; small bowel

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BIOCHEMICAL MARKER; CASPASE 3; CD68 ANTIGEN; CYCLINE; CYTOCHROME C; GELATINASE B; GLUCOCORTICOID RECEPTOR; GLUTATHIONE PEROXIDASE; HEME OXYGENASE 1; HISTONE H2AX; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MELATONIN; MITOCHONDRIAL PROTEIN; MYELOPEROXIDASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE DERIVED MESENCHYMAL STEM CELL; ADIPOSE DERIVED STEM CELL; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOSOL; DNA DAMAGE; INFLAMMATION; INTESTINE ISCHEMIA; INTESTINE MUCOSA PERMEABILITY; LEUKOCYTE COUNT; MALE; MESENCHYMAL STEM CELL; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SUPERIOR MESENTERIC ARTERY; TREATMENT OUTCOME; TUNEL ASSAY; ADIPOSE TISSUE; ALLOGRAFT; ANIMAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; SMALL INTESTINE; SPRAGUE DAWLEY RAT;

ADIPOSE TISSUE; ALLOGRAFTS; ANIMALS; GENE EXPRESSION REGULATION; INFLAMMATION; INTESTINE, SMALL; MALE; MELATONIN; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 84938422737     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12251     Document Type: Article

References (39)

1. Evennett NJ, Petrov MS, Mittal A, et al., Systematic review and pooled estimates for the diagnostic accuracy of serological markers for intestinal ischemia. World J Surg 2009; 33: 1374-1383.
2. Wyers MC,. Acute mesenteric ischemia: diagnostic approach and surgical treatment. Semin Vasc Surg 2010; 23: 9-20.
3. Wang MQ, Liu FY, Duan F, et al., Acute symptomatic mesenteric venous thrombosis: treatment by catheter-directed thrombolysis with transjugular intrahepatic route. Abdom Imaging 2011; 36: 390-398.
4. Iacobellis F, Berritto D, Fleischmann D, et al., CT findings in acute, subacute, and chronic ischemic colitis: suggestions for diagnosis. Biomed Res Int 2014; 2014: 895248.
5. Romano S, Romano L, Grassi R,. Multidetector row computed tomography findings from ischemia to infarction of the large bowel. Eur J Radiol 2007; 61: 433-441.
6. Matsumoto S, Sekine K, Funaoka H, et al., Diagnostic performance of plasma biomarkers in patients with acute intestinal ischaemia. Br J Surg 2014; 101: 232-238.
7. Tsunoyama T, Pham TD, Fujita T, et al., Identification of intestinal wall abnormalities and ischemia by modeling spatial uncertainty in computed tomography imaging findings. Comput Methods Programs Biomed 2014; 117: 30-39.
8. Tsunoyama T, Pham TD, Fujita T, et al., Automated CT detection of intestinal abnormalities and ischemia for decision making in emergency medicine. Biomed Eng Online 2014; 13 (Suppl 1): S3.
9. Kramer SC, Gorich J, Oertel F, et al., [Non-occlusive mesenteric ischemia]. Rofo 2003; 175: 1177-1183.
10. O'Neill S, Elder K, Harrison SJ, et al., Predictors of severity in ischaemic colitis. Int J Colorectal Dis 2012; 27: 187-191.
11. Acosta S,. Surgical management of peritonitis secondary to acute superior mesenteric artery occlusion. World J Gastroenterol 2014; 20: 9936-9941.
12. Sise MJ,. Acute mesenteric ischemia. Surg Clin North Am 2014; 94: 165-181.
13. Wain RA, Hines G,. Surgical management of mesenteric occlusive disease: a contemporary review of invasive and minimally invasive techniques. Cardiol Rev 2008; 16: 69-75.
14. Paladino NC, Inviati A, Di Paola V, et al., Predictive factors of mortality in patients with acute mesenteric ischemia. A retrospective study. Ann Ital Chir 2014; 85: 265-270.
15. Fadillioglu E, Kurcer Z, Parlakpinar H, et al., Melatonin treatment against remote organ injury induced by renal ischemia reperfusion injury in diabetes mellitus. Arch Pharm Res 2008; 31: 705-712.
16. Cuzzocrea S, Costantino G, Mazzon E, et al., Beneficial effects of melatonin in a rat model of splanchnic artery occlusion and reperfusion. J Pineal Res 2000; 28: 52-63.
17. Thum T, Bauersachs J, Poole-Wilson PA, et al., The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol 2005; 46: 1799-1802.
18. Maumus M, Guerit D, Toupet K, et al., Mesenchymal stem cell-based therapies in regenerative medicine: applications in rheumatology. Stem Cell Res Ther 2011; 2: 14.
19. Chen YT, Sun CK, Lin YC, et al., Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction. J Transl Med 2011; 9: 51.
20. Sun CK, Yen CH, Lin YC, et al., Autologous transplantation of adipose-derived mesenchymal stem cells markedly reduced acute ischemia-reperfusion lung injury in a rodent model. J Transl Med 2011; 9: 118.
21. Yip HK, Chang YC, Wallace CG, et al., Melatonin treatment improves adipose-derived mesenchymal stem cell therapy for acute lung ischemia-reperfusion injury. J Pineal Res 2013; 54: 207-221.
22. Wang D, Li J, Zhang Y, et al., Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study. Arthritis Res Ther 2014; 16: R79.
23. Insausti CL, Blanquer M, Garcia-Hernandez AM, et al., Amniotic membrane-derived stem cells: immunomodulatory properties and potential clinical application. Stem Cells Cloning 2014; 7: 53-63.
24. Kox M, Pickkers P,. Reply: Mesenchymal stromal (stem) cell therapy: an emerging immunomodulatory strategy for the adjunctive treatment of sepsis. Am J Respir Crit Care Med 2014; 189: 364-365.
25. Ben-Ami E, Miller A, Berrih-Aknin S,. T cells from autoimmune patients display reduced sensitivity to immunoregulation by mesenchymal stem cells: role of IL-2. Autoimmun Rev 2014; 13: 187-196.
26. Galano A, Tan DX, Reiter RJ,. On the free radical scavenging activities of melatonin's metabolites. AFMK and AMK. J Pineal Res 2013; 54: 245-257.
27. Zhang HM, Zhang Y,. Melatonin: a well-documented antioxidant with conditional pro-oxidant actions. J Pineal Res 2014; 57: 131-146.
28. Mauriz JL, Collado PS, Veneroso C, et al., A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives. J Pineal Res 2013; 54: 1-14.
29. Galano A, Tan DX, Reiter RJ,. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011; 51: 1-16.
30. Chen YT, Chiang HJ, Chen CH, et al., Melatonin treatment further improves adipose-derived mesenchymal stem cell therapy for acute interstitial cystitis in rat. J Pineal Res 2014; 57: 248-261.
31. Chen HH, Chang CL, Lin KC, et al., Melatonin augments apoptotic adipose-derived mesenchymal stem cell treatment against sepsis-induced acute lung injury. Am J Transl Res 2014; 6: 439-458.
32. Ates B, Yilmaz I, Geckil H, et al., Protective role of melatonin given either before ischemia or prior to reperfusion on intestinal ischemia-reperfusion damage. J Pineal Res 2004; 37: 149-152.
33. Huang CY, Hsiao JK, Lu YZ, et al., Anti-apoptotic PI3K/Akt signaling by sodium/glucose transporter 1 reduces epithelial barrier damage and bacterial translocation in intestinal ischemia. Lab Invest 2011; 91: 294-309.
34. Sun CK, Lee FY, Kao YH, et al., Systemic combined melatonin-mitochondria treatment improves acute respiratory distress syndrome in the rat. J Pineal Res 2015; 58: 137-150.
35. Kesik V, Guven A, Vurucu S, et al., Melatonin and 1400 W ameliorate both intestinal and remote organ injury following mesenteric ischemia/reperfusion. J Surg Res 2009; 157: e97-e105.
36. Sun CK, Leu S, Hsu SY, et al., Mixed serum-deprived and normal adipose-derived mesenchymal stem cells against acute lung ischemia-reperfusion injury in rats. Am J Transl Res 2015; 7: 209-231.
37. Abdi R, Fiorina P, Adra CN, et al., Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes 2008; 57: 1759-1767.
38. Wang Y, Chen X, Cao W, et al., Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat Immunol 2014; 15: 1009-1016.
39. Madrigal M, Rao KS, Riordan NH,. A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods. J Transl Med 2014; 12: 260.